Source:http://linkedlifedata.com/resource/pubmed/id/10351245
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1999-5-10
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
H
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0739-9413
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
17
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
33-5
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:10351245-Cost-Benefit Analysis,
pubmed-meshheading:10351245-Drug Costs,
pubmed-meshheading:10351245-Health Services Research,
pubmed-meshheading:10351245-Insurance Coverage,
pubmed-meshheading:10351245-Managed Care Programs,
pubmed-meshheading:10351245-Nonprescription Drugs,
pubmed-meshheading:10351245-Self Medication,
pubmed-meshheading:10351245-United States
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
OTCs: the wild card in cost effectiveness.
|
| pubmed:publicationType |
Journal Article
|